Judge Axes 2 Anti-Seizure Drug Patents, Upholds 3 Others

By Adam Lidgett (September 16, 2022, 3:57 PM EDT) -- A Delaware federal judge has found that claims in a pair of patents related to epileptic seizure treatment Aptiom were invalid, while at the same time finding that patent challenger Alkem failed to prove that other patents on the product were invalid....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!